Peer-reviewedCC BY-NCDermatology practical & conceptual
Palmoplantar Pustulosis Induced by Intravenous Anifrolumab: An Emerging Dermatologic Adverse Event?
- 1Department of Dermatology, Spedali Civili, University of Brescia, Brescia, Italy.
- 2Pathology Department, University of Brescia, ASST Spedali Civili di Brescia, Italy.
Related
- Acute generalized exanthematous pustulosis following nemolizumab therapy in a patient with atopic dermatitis
- Punctate Palmoplantar Keratoderma Type 1 With a Multigenerational Family History: A Case Report
- Dermoscopic clues for differentiating mycosis fungoides palmaris et plantaris from palmoplantar eczema.
- Demodex Folliculitis Following Anifrolumab Infusion.
- Sustained multisite response to anifrolumab in refractory Chilblain lupus erythematosus.
BibTeX
@article{zanghi2026palmoplantar,
title = {{Palmoplantar Pustulosis Induced by Intravenous Anifrolumab: An Emerging Dermatologic Adverse Event?}},
author = {Silvia Zanghì and Stefano Bighetti and Luca Bettolini and Iacopo Ghini and Mariateresa Rossi and Vincenzo Maione},
journal = {Dermatology practical \& conceptual},
year = {2026},
month = jul,
doi = {10.5826/dpc.1603a6789},
url = {https://europepmc.org/article/MED/42858422},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Palmoplantar Pustulosis Induced by Intravenous Anifrolumab: An Emerging Dermatologic Adverse Event?
AU - Silvia Zanghì
AU - Stefano Bighetti
AU - Luca Bettolini
AU - Iacopo Ghini
AU - Mariateresa Rossi
AU - Vincenzo Maione
PY - 2026
DA - 2026/07/31
JO - Dermatology practical & conceptual
DO - 10.5826/dpc.1603a6789
UR - https://europepmc.org/article/MED/42858422
SN - 2160-9381
ER -